Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
Not Applicable
Completed
- Conditions
- Hydrops in Keratoconus
- Interventions
- Drug: Gas SF6 (Sulfur Hexafluoride)
- Registration Number
- NCT00593190
- Lead Sponsor
- HaEmek Medical Center, Israel
- Brief Summary
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
- Hydrops
Exclusion Criteria
- Age < 18 years old
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Gas SF6 (Sulfur Hexafluoride) -
- Primary Outcome Measures
Name Time Method Hydrops resulotion weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
HaEmek Medical Center
🇮🇱Afula, Israel